Johnson&Johnson dans l'actualité
Leader mondial de l'innovation en soins de santé
Tamtam a trouvé 20 articles récents sur Johnson&Johnson.
- Johnson & Johnson’s Ottava Is Set to Revolutionize Robotic Surgery
- 24/7 Market News Highlights NeOnc, Revolution Medicines, Moderna, Merck, Johnson & Johnson and Genmab, AbbVie in 2026 Cancer Treatment Advances
- J&J delivers Shockwave data sustaining below-the-knee gains for two years
- RBC Capital maintains Outperform rating on Johnson & Johnson, $290 price target
- Is Johnson & Johnson (NYSE:JNJ) dividend back in view as rate bets shift?
- Most Women Do Not Link Menopause to Changing Eye Health, New Johnson & Johnson Survey Says
- Johnson & Johnson reports sustained psoriasis skin clearance
- Johnson & Johnson announces new ICOTYDE® (icotrokinra) data in difficult-to-treat plaque psoriasis with proven durability through 2-years, affirming its use as a powerful first line systemic therapy
- History Says Johnson & Johnson Beats Medtronic. Here's Why I'd Still Consider MDT for the Next Decade.
- Johnson & Johnson (NYSE:JNJ) Raises Its Payout
- Johnson & Johnson wins trial over Massachusetts woman’s talc lawsuit
- 3 Reasons Johnson & Johnson Is Still a Buy With Its Stock Near a Record High
- Johnson & Johnson (NYSE:JNJ) Steady as Imaavy and Tremfya Trial Updates Keep Healthcare Dividend Story in Focus
- Johnson & Johnson (JNJ) Stock May Be Undervalued As Its 96% Run Continues
- Johnson & Johnson Q3 Preview: Analyst Projects In-Line Sales, Earnings Miss
- Johnson & Johnson (NYSE:JNJ) Stock: Newer Medicines Absorb the Loss of Stelara Sales
- Johnson & Johnson: Strong Catalysts, But I’m Staying At Hold (NYSE:JNJ)
- Johnson & Johnson Reports IMAAVY Myasthenia Gravis Data
- Johnson & Johnson's psoriasis drug Icotyde could hit $4.5B in peak sales, BofA says
- How Does Johnson & Johnson (NYSE:JNJ) Keep Its Distribution Streak Intact?
Articles collectés par Tamtam et retenus lorsqu'ils portent sur l'entreprise, des plus récents aux plus anciens. Chacun renvoie à sa source.
Vous vendez à des entreprises comme Johnson&Johnson ?
Tamtam trouve les entreprises qui correspondent à votre client idéal, analyse chaque compte et vous dit qui contacter, et quand.
Trouver des entreprises similaires